Canada Pension Plan Investment Board
GYRE icon

Canada Pension Plan Investment Board’s Gyre Therapeutics GYRE Stock Holding History

Canada Pension Plan Investment Board’s Portfolio GYRE Stock Details GYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-10
Closed -$37K – 1257
2014
Q1 		$37K Buy
+10
New +$37K ﹤0.01% 1176

Other funds holding GYRE

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TC
TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Canada Pension Plan Investment Board's GYRE Position: Q2 2014 in Review

Canada Pension Plan Investment Board sold out of Gyre Therapeutics (GYRE) in Q2 2014, closing a stake of 10 shares — an estimated $37K sold.

Canada Pension Plan Investment Board first reported a position in GYRE in Q1 2014 and held it in 1 quarter. The position peaked at $37K in Q1 2014. 63 funds tracked by Wall St. Rank hold GYRE as of Q2 2014.

  • Canada Pension Plan Investment Board reported no remaining Gyre Therapeutics position as of Q2 2014 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 10 Gyre Therapeutics shares in Q2 2014, an estimated $37K.
  • Canada Pension Plan Investment Board first reported a position in Gyre Therapeutics in Q1 2014 and held it in 1 quarter.
  • Canada Pension Plan Investment Board's Gyre Therapeutics position peaked at $37K in Q1 2014.
  • 63 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q2 2014.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2014, filed 13 Aug 2014.